Related references
Note: Only part of the references are listed.Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis Regulator
Kazumi Fujimoto et al.
PLOS ONE (2013)
Salusin-β accelerates inflammatory responses in vascular endothelial cells via NF-κB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro
Takayuki Koya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Enhanced expression of salusin-β contributes to progression of atherosclerosis in LDL receptor deficient mice
Cheng-Hua Zhou et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2012)
Associations of serum salusin-alpha levels with atherosclerosis and left ventricular diastolic dysfunction in essential hypertension
Y. Ti et al.
JOURNAL OF HUMAN HYPERTENSION (2012)
Chronic infusion of salusin-α and -β exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice
Masaharu Nagashima et al.
ATHEROSCLEROSIS (2010)
Release of salusin-β from human monocytes/macrophages
Kengo Sato et al.
REGULATORY PEPTIDES (2010)
Impact of salusin-α and -β on human macrophage foam cell formation and coronary atherosclerosis
Takuya Watanabe et al.
CIRCULATION (2008)
Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage
Stefan M. Gehrig et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Serum salusin-α levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients
Takuya Watanabe et al.
HYPERTENSION RESEARCH (2008)
Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall
Ravi M. Rao et al.
CIRCULATION RESEARCH (2007)
Presence of immunoreactive salusin-α in human serum and urine
Kengo Sato et al.
PEPTIDES (2006)
Circulating markers of endothelial function in cardiovascular disease
Joel Constans et al.
CLINICA CHIMICA ACTA (2006)
Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities
M Shichiri et al.
NATURE MEDICINE (2003)
Molecular mechanisms mediating inflammation in vascular disease - Special reference to monocyte chemoattractant protein-1
K Egashira
HYPERTENSION (2003)
Macrophages, inflammation, and atherosclerosis
MF Linton et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model
MA Hofmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice
EG Lee et al.
SCIENCE (2000)
Share Paper
